SCHEMBL24496347

SCHEMBL24496347

CNS(=O)(=O)c1ccc(Nc2ccc(C3CCC3)cn2)c(-c2cn(C)cn2)c1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TEAD1 P28347 3/20 0.55
YAP1 P46937 1/20 0.55
GABRA1 P14867 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRA3 P34903 1/20 0.37
GABRA2 P47869 1/20 0.37
KCNH2 Q12809 1/20 0.37
BRAF P15056 6/20 0.36
TNNI3K Q59H18 6/20 0.36
BRD4 O60885 1/20 0.35
CSF1R P07333 1/20 0.35
TYK2 P29597 1/20 0.35
KDM1A O60341 1/20 0.35
MAOA P21397 1/20 0.35
CDK4 P11802 1/20 0.34
CDK6 Q00534 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29648361 1.00 TEAD1 (0.55) TEAD1YAP1GABRA1GABRG2GABRB3
SCHEMBL29438907 0.96 TEAD1 (0.56) TEAD1YAP1GABRA1GABRG2GABRB3
SCHEMBL22718179 0.96 TEAD1 (0.56) TEAD1YAP1GABRA1GABRG2GABRB3
SCHEMBL29648306 0.81 TEAD1 (0.58) TEAD1YAP1GABRA1GABRG2GABRB3
SCHEMBL22718188 0.81 TEAD1 (0.66) TEAD1YAP1GABRA1GABRG2GABRB3
SCHEMBL29438838 0.81 TEAD1 (0.66) TEAD1YAP1GABRA1GABRG2GABRB3
SCHEMBL29648310 0.81 TEAD1 (0.58) TEAD1YAP1GABRA1GABRG2GABRB3
SCHEMBL24496007 0.81 TEAD1 (0.58) TEAD1YAP1GABRA1GABRG2GABRB3
SCHEMBL24496009 0.81 TEAD1 (0.58) TEAD1YAP1GABRA1GABRG2GABRB3
SCHEMBL22843438 0.80 TEAD1 (0.40) TEAD1YAP1GABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4281073-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2023-11-29 EP disclosed
WO-2022120355-A1 TEAD DEGRADERS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 WO disclosed
WO-2022120353-A1 TEAD INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 WO disclosed